Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

OMG siRNA (Human)

SiRNA to inhibit OMG expression using RNA interference

Product Specifications

Product Name Alternative

OMGP; Oligodendrocyte-myelin glycoprotein

Reactivity

H

Source

Synthetic

Applications

RNAi

Purity

> 97%

Form

Lyophilized powder

Components

We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of human OMG gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.

Storage Conditions

Shipped at 4 °C. Store at -20 °C for one year.

Specificity

OMG siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.

NCBI Gene Symbol

OMG

Quality Control

Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.

SwissProt (Human)

P23515

Entrez GeneHuman

4974

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

PE/XFD700 Anti-human CD150 Antibody *SLAM.4*
115001O0-AAT 25 Tests

PE/XFD700 Anti-human CD150 Antibody *SLAM.4*

Sign In for Pricing
View Details
Tinazoline
HY-W720736-01 5 mg

Tinazoline

Sign In for Pricing
View Details
Tinazoline
HY-W720736-02 10 mg

Tinazoline

Sign In for Pricing
View Details
Tinazoline
HY-W720736-03 25 mg

Tinazoline

Sign In for Pricing
View Details
Tinazoline
HY-W720736-04 50 mg

Tinazoline

Sign In for Pricing
View Details
Tinazoline
HY-W720736-05 100 mg

Tinazoline

Sign In for Pricing
View Details